AP

Abhishek Patra

Active Director Director DIN 10595073
DIN 10595073 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Patra

Data last updated:

Abhishek Patra is a Director at Fantasize Pharmaceutical Private Limited (since 2024). The company operates in Pharma.

DIN 10595073
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Apr 20242024Active

Board colleagues of Abhishek Patra

NameDINCompanyDesignation
Antara Das11499670Fantasize Pharmaceutical Private LimitedAdditional Director
Tanmoy Ghosh10595072Fantasize Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fantasize Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Abhishek Patra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Patra

Abhishek Patra currently holds 1 directorship: Fantasize Pharmaceutical Private Limited (Director, since 18 Apr 2024).

Abhishek Patra was first appointed on 18 Apr 2024 as Director at Fantasize Pharmaceutical Private Limited.

The current boards of Abhishek Patra's companies include Antara Das (Fantasize Pharmaceutical Private Limited), Tanmoy Ghosh (Fantasize Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available